BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 24037379)

  • 1. X-ray structure of dopamine transporter elucidates antidepressant mechanism.
    Penmatsa A; Wang KH; Gouaux E
    Nature; 2013 Nov; 503(7474):85-90. PubMed ID: 24037379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Snapshot of antidepressants at work: the structure of neurotransmitter transporter proteins.
    Cuboni S; Hausch F
    Angew Chem Int Ed Engl; 2014 May; 53(20):5008-9. PubMed ID: 24729171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitter and psychostimulant recognition by the dopamine transporter.
    Wang KH; Penmatsa A; Gouaux E
    Nature; 2015 May; 521(7552):322-7. PubMed ID: 25970245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for action by diverse antidepressants on biogenic amine transporters.
    Wang H; Goehring A; Wang KH; Penmatsa A; Ressler R; Gouaux E
    Nature; 2013 Nov; 503(7474):141-5. PubMed ID: 24121440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.
    Zhou Z; Zhen J; Karpowich NK; Goetz RM; Law CJ; Reith ME; Wang DN
    Science; 2007 Sep; 317(5843):1390-3. PubMed ID: 17690258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.
    Singh SK; Yamashita A; Gouaux E
    Nature; 2007 Aug; 448(7156):952-6. PubMed ID: 17687333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-ray structures of LeuT in substrate-free outward-open and apo inward-open states.
    Krishnamurthy H; Gouaux E
    Nature; 2012 Jan; 481(7382):469-74. PubMed ID: 22230955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine.
    Penmatsa A; Wang KH; Gouaux E
    Nat Struct Mol Biol; 2015 Jun; 22(6):506-508. PubMed ID: 25961798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray structures and mechanism of the human serotonin transporter.
    Coleman JA; Green EM; Gouaux E
    Nature; 2016 Apr; 532(7599):334-9. PubMed ID: 27049939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition.
    Zeppelin T; Ladefoged LK; Sinning S; Periole X; Schiøtt B
    PLoS Comput Biol; 2018 Jan; 14(1):e1005907. PubMed ID: 29329285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging structure-function relationships defining monoamine NSS transporter substrate and ligand affinity.
    Wang CI; Lewis RJ
    Biochem Pharmacol; 2010 Apr; 79(8):1083-91. PubMed ID: 19954741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of chloride interaction with neurotransmitter:sodium symporters.
    Zomot E; Bendahan A; Quick M; Zhao Y; Javitch JA; Kanner BI
    Nature; 2007 Oct; 449(7163):726-30. PubMed ID: 17704762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulation of human dopamine transporter activity under conditions promoting its dimerization.
    Cheng MH; Garcia-Olivares J; Wasserman S; DiPietro J; Bahar I
    J Biol Chem; 2017 Jul; 292(30):12471-12482. PubMed ID: 28584050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is an antidepressant binding site doing in a bacterial transporter?
    Rudnick G
    ACS Chem Biol; 2007 Sep; 2(9):606-9. PubMed ID: 17894444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structure of LeuT in an inward-facing occluded conformation reveals mechanism of substrate release.
    Gotfryd K; Boesen T; Mortensen JS; Khelashvili G; Quick M; Terry DS; Missel JW; LeVine MV; Gourdon P; Blanchard SC; Javitch JA; Weinstein H; Loland CJ; Nissen P; Gether U
    Nat Commun; 2020 Feb; 11(1):1005. PubMed ID: 32081981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of LeuT as a model in elucidating binding sites for substrates and inhibitors in neurotransmitter transporters.
    Loland CJ
    Biochim Biophys Acta; 2015 Mar; 1850(3):500-10. PubMed ID: 24769398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter.
    Shan J; Javitch JA; Shi L; Weinstein H
    PLoS One; 2011 Jan; 6(1):e16350. PubMed ID: 21298009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue.
    Zhao Y; Terry DS; Shi L; Quick M; Weinstein H; Blanchard SC; Javitch JA
    Nature; 2011 Jun; 474(7349):109-13. PubMed ID: 21516104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism for intracellular release of Na+ by neurotransmitter/sodium symporters.
    Malinauskaite L; Quick M; Reinhard L; Lyons JA; Yano H; Javitch JA; Nissen P
    Nat Struct Mol Biol; 2014 Nov; 21(11):1006-12. PubMed ID: 25282149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template.
    Indarte M; Madura JD; Surratt CK
    Proteins; 2008 Feb; 70(3):1033-46. PubMed ID: 17847094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.